Business
Press Release Nov 22 2023
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated November 22, 2023, titled "Press Release - Evive Biotech and Acrotech Biopharma Announce FDA Approval of Ryzneuta for Chemotherapy-Induced Neutropenia (CIN)".
About this update from Aurobindo Pharma Ltd
[{"type":"text","content":" Aurobindo Pharma Limited has informed the Exchange regarding a press release dated November 22, 2023, titled \"Press Release - Evive Biotech and Acrotech Biopharma Announce FDA Approval of Ryzneuta for Chemotherapy-Induced Neutropenia (CIN)\". View Attachment","length":406,"tagName":"div"}]